RGSL1
gene geneOn this page
Summary
RGSL1 (regulator of G protein signaling like 1, HGNC:18636) is a protein-coding gene on chromosome 1q25.3, encoding Regulator of G-protein signaling protein-like (A5PLK6).
Predicted to be located in membrane.
Source: NCBI Gene 353299 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 168 total
- MANE Select transcript:
NM_001137669
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18636 |
| Approved symbol | RGSL1 |
| Name | regulator of G protein signaling like 1 |
| Location | 1q25.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000121446 |
| Ensembl biotype | protein_coding |
| OMIM | 611012 |
| Entrez | 353299 |
Gene structure
Transcript identifiers
Ensembl transcripts: 22 — 8 protein_coding, 6 nonsense_mediated_decay, 5 protein_coding_CDS_not_defined, 3 retained_intron
ENST00000294854, ENST00000367561, ENST00000415960, ENST00000416676, ENST00000422241, ENST00000426890, ENST00000427189, ENST00000436031, ENST00000437548, ENST00000443996, ENST00000444367, ENST00000447374, ENST00000456971, ENST00000634342, ENST00000634626, ENST00000634679, ENST00000634723, ENST00000634758, ENST00000634801, ENST00000635407, ENST00000635539, ENST00000648414
RefSeq mRNA: 2 — MANE Select: NM_001137669
NM_001137669, NM_001366934
CCDS: CCDS58049
Canonical transcript exons
ENST00000294854 — 22 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002342422 | 182488980 | 182489202 |
| ENSE00002606110 | 182450146 | 182450178 |
| ENSE00003468888 | 182553455 | 182553541 |
| ENSE00003495994 | 182458319 | 182458393 |
| ENSE00003498764 | 182551100 | 182551209 |
| ENSE00003507074 | 182530244 | 182530361 |
| ENSE00003511615 | 182548317 | 182548455 |
| ENSE00003523613 | 182548700 | 182548824 |
| ENSE00003534828 | 182472396 | 182472557 |
| ENSE00003545570 | 182556024 | 182556222 |
| ENSE00003571805 | 182488285 | 182488347 |
| ENSE00003591040 | 182493022 | 182493129 |
| ENSE00003598910 | 182554627 | 182554693 |
| ENSE00003603675 | 182453958 | 182454040 |
| ENSE00003614882 | 182527579 | 182527772 |
| ENSE00003614898 | 182540247 | 182540421 |
| ENSE00003621365 | 182473575 | 182474542 |
| ENSE00003641397 | 182532662 | 182532791 |
| ENSE00003670089 | 182522004 | 182522109 |
| ENSE00003683257 | 182530790 | 182530910 |
| ENSE00003692856 | 182460004 | 182460133 |
| ENSE00003850188 | 182560279 | 182560597 |
Expression profiles
Bgee: expression breadth broad, 84 present calls, max score 88.64.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0183 / max 20.7499, expressed in 4 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 7041 | 0.0183 | 4 |
Top tissues by expression
230 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cervix squamous epithelium | UBERON:0006922 | 88.64 | gold quality |
| type B pancreatic cell | CL:0000169 | 88.32 | gold quality |
| olfactory bulb | UBERON:0002264 | 87.32 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 87.17 | gold quality |
| left testis | UBERON:0004533 | 83.49 | gold quality |
| right testis | UBERON:0004534 | 83.16 | gold quality |
| male germ cell | CL:0000015 | 81.50 | silver quality |
| testis | UBERON:0000473 | 80.83 | gold quality |
| sperm | CL:0000019 | 80.74 | silver quality |
| thymus | UBERON:0002370 | 77.79 | gold quality |
| diaphragm | UBERON:0001103 | 77.44 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.16 | gold quality |
| upper arm skin | UBERON:0004263 | 76.82 | gold quality |
| cervix epithelium | UBERON:0004801 | 75.74 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 74.97 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 74.03 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 73.87 | gold quality |
| hair follicle | UBERON:0002073 | 73.31 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 72.98 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 72.82 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 72.69 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 72.41 | gold quality |
| cardia of stomach | UBERON:0001162 | 72.15 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 72.08 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 72.04 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 71.62 | gold quality |
| trachea | UBERON:0003126 | 71.53 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 71.51 | gold quality |
| ventral tegmental area | UBERON:0002691 | 71.46 | gold quality |
| vastus lateralis | UBERON:0001379 | 71.27 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.28 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- A detailed mapping of the breakpoints revealed intragenic microdeletions affecting the coding regions of RGSL2, RGSL1. (PMID:18521847)
- Missense mutations in RGSL1 gene is associated with breast cancer. (PMID:21135262)
- Data indicate that multiplex ligation-dependent probe amplification (MLPA) probes (Fig. 2) corresponding to the RGSL2, RGSL1 and RGS16 genes showed 64.5 % tumour samples with copy number gains and 5 % tumour samples with copy number losses. (PMID:23248035)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Rgsl1 | ENSMUSG00000042641 |
| rattus_norvegicus | Rgsl1 | ENSRNOG00000026952 |
Paralogs (23): RGS11 (ENSG00000076344), RGS1 (ENSG00000090104), RGS17 (ENSG00000091844), AXIN1 (ENSG00000103126), RGS9 (ENSG00000108370), RGS2 (ENSG00000116741), RGS4 (ENSG00000117152), RGS13 (ENSG00000127074), RGS22 (ENSG00000132554), RGS8 (ENSG00000135824), RGS3 (ENSG00000138835), RGS5 (ENSG00000143248), RGS16 (ENSG00000143333), RGS20 (ENSG00000147509), RGS10 (ENSG00000148908), RGS18 (ENSG00000150681), RGS12 (ENSG00000159788), AXIN2 (ENSG00000168646), RGS14 (ENSG00000169220), RGS19 (ENSG00000171700), RGS6 (ENSG00000182732), RGS7 (ENSG00000182901), RGS21 (ENSG00000253148)
Protein
Protein identifiers
Regulator of G-protein signaling protein-like — A5PLK6 (reviewed: A5PLK6)
All UniProt accessions (14): A0A0U1RQD8, A0A0U1RRA3, A0A0U1RRF3, A0A0U1RRF6, A0A0U1RRG0, A0A0U1RRN0, A0A3B3ISC9, A5PLK6, H3BNQ0, H3BNR3, H3BNS3, H3BRN5, H3BU64, H3BVE8
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Isoforms (6)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A5PLK6-1 | 1 | yes |
| A5PLK6-2 | 2 | |
| A5PLK6-3 | 3 | |
| A5PLK6-4 | 4 | |
| A5PLK6-5 | 5 | |
| A5PLK6-6 | 6 |
RefSeq proteins (2): NP_001131141, NP_001353863 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR016137 | RGS | Domain |
| IPR036305 | RGS_sf | Homologous_superfamily |
| IPR044926 | RGS_subdomain_2 | Homologous_superfamily |
| IPR053282 | RGS_domain-containing | Family |
Pfam: PF00615
UniProt features (17 total): splice variant 8, sequence variant 2, sequence conflict 2, chain 1, transmembrane region 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A5PLK6-F1 | 67.79 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-416476 | G alpha (q) signalling events |
| R-HSA-418594 | G alpha (i) signalling events |
| R-HSA-418597 | G alpha (z) signalling events |
MSigDB gene sets: 34 (showing top):
MULLIGHAN_NPM1_SIGNATURE_3_UP, REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS, TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN, WTGAAAT_UNKNOWN, YY1_01, REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS, QI_PLASMACYTOMA_DN, MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP, chr1q25, CTIP_DN.V1_UP, MIR4700_5P, MIR6129, MIR4510, MIR6130, MIR4667_5P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| GPCR downstream signalling | 3 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
662 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RGSL1 | TEX35 | Q5T0J7 | 896 |
| RGSL1 | RALGPS2 | Q86X27 | 842 |
| RGSL1 | RGS8 | P57771 | 792 |
| RGSL1 | RGS16 | O15492 | 792 |
| RGSL1 | RGS13 | O14921 | 777 |
| RGSL1 | RGS17 | Q9UGC6 | 776 |
| RGSL1 | RGS18 | Q9NS28 | 776 |
| RGSL1 | RGS20 | O76081 | 771 |
| RGSL1 | RGS21 | Q2M5E4 | 771 |
| RGSL1 | RGS5 | O15539 | 764 |
| RGSL1 | RGS6 | P49758 | 761 |
| RGSL1 | RGS10 | O43665 | 759 |
| RGSL1 | RGS12 | O14924 | 758 |
| RGSL1 | RGS11 | O94810 | 756 |
| RGSL1 | RGS19 | P49795 | 746 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DCUN1D1 | RGSL1 | psi-mi:“MI:0914”(association) | 0.350 |
| P | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (9): RGSL1 (Two-hybrid), RGSL1 (Synthetic Lethality), MAGT1 (Proximity Label-MS), RGSL1 (Affinity Capture-RNA), D2HGDH (Co-fractionation), REXO2 (Co-fractionation), RGSL1 (Cross-Linking-MS (XL-MS)), RGSL1 (Cross-Linking-MS (XL-MS)), RGSL1 (Affinity Capture-MS)
ESM2 similar proteins: A2RRS8, A4D1B5, A5PLK6, D3Z6S9, E7FA21, G3UYX5, O75747, O75901, O88480, O88869, Q2T9P0, Q3UMB5, Q3UPC7, Q3URV1, Q402B2, Q4R9E9, Q5SUS0, Q5T0N1, Q5XI56, Q5XX13, Q642P2, Q6DHV5, Q6INI0, Q6P2C0, Q7L0X2, Q80X60, Q86VV8, Q86WZ0, Q8CDN1, Q8IV33, Q8IXR9, Q8K342, Q8N7B9, Q8N7X0, Q8ND61, Q8NE09, Q8NG48, Q8R4Y8, Q8TDY2, Q8TEV9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
168 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 148 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3743 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:182472461:G:GT | donor_gain | 1.0000 |
| 1:182472518:G:GT | donor_gain | 1.0000 |
| 1:182472519:A:T | donor_gain | 1.0000 |
| 1:182472528:GGGTG:G | donor_gain | 1.0000 |
| 1:182472529:GGTGG:G | donor_gain | 1.0000 |
| 1:182472530:G:T | donor_gain | 1.0000 |
| 1:182472558:G:GG | donor_gain | 1.0000 |
| 1:182530235:A:AG | acceptor_gain | 1.0000 |
| 1:182530236:T:G | acceptor_gain | 1.0000 |
| 1:182530239:TCTA:T | acceptor_loss | 1.0000 |
| 1:182530240:CTA:C | acceptor_loss | 1.0000 |
| 1:182530241:TA:T | acceptor_loss | 1.0000 |
| 1:182530242:A:AG | acceptor_gain | 1.0000 |
| 1:182530243:G:GT | acceptor_gain | 1.0000 |
| 1:182530243:GA:G | acceptor_gain | 1.0000 |
| 1:182530243:GAA:G | acceptor_gain | 1.0000 |
| 1:182530243:GAAGA:G | acceptor_gain | 1.0000 |
| 1:182530358:AGTGG:A | donor_loss | 1.0000 |
| 1:182530359:GTG:G | donor_gain | 1.0000 |
| 1:182530360:TGG:T | donor_loss | 1.0000 |
| 1:182530362:G:A | donor_loss | 1.0000 |
| 1:182530362:G:GG | donor_gain | 1.0000 |
| 1:182530363:T:G | donor_loss | 1.0000 |
| 1:182530364:GA:G | donor_loss | 1.0000 |
| 1:182530365:AGTAT:A | donor_loss | 1.0000 |
| 1:182532657:CCCA:C | acceptor_loss | 1.0000 |
| 1:182532658:CCA:C | acceptor_loss | 1.0000 |
| 1:182532660:A:AG | acceptor_gain | 1.0000 |
| 1:182532660:AGA:A | acceptor_loss | 1.0000 |
| 1:182532661:G:GA | acceptor_loss | 1.0000 |
AlphaMissense
7239 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:182548817:T:A | W976R | 0.995 |
| 1:182548817:T:C | W976R | 0.995 |
| 1:182540346:G:C | R865P | 0.994 |
| 1:182458361:T:A | W47R | 0.992 |
| 1:182458361:T:C | W47R | 0.992 |
| 1:182548705:T:A | N938K | 0.992 |
| 1:182548705:T:G | N938K | 0.992 |
| 1:182532762:T:C | L822P | 0.989 |
| 1:182548401:A:C | K918N | 0.989 |
| 1:182548401:A:T | K918N | 0.989 |
| 1:182540393:G:C | D881H | 0.988 |
| 1:182540345:C:A | R865S | 0.987 |
| 1:182540394:A:C | D881A | 0.987 |
| 1:182548400:A:T | K918I | 0.987 |
| 1:182551101:T:C | F979L | 0.987 |
| 1:182551103:T:A | F979L | 0.987 |
| 1:182551103:T:G | F979L | 0.987 |
| 1:182460031:T:A | W67R | 0.986 |
| 1:182460031:T:C | W67R | 0.986 |
| 1:182548423:T:C | F926L | 0.986 |
| 1:182548425:C:A | F926L | 0.986 |
| 1:182548425:C:G | F926L | 0.986 |
| 1:182527668:T:C | F674S | 0.984 |
| 1:182527631:T:C | F662L | 0.983 |
| 1:182527633:C:A | F662L | 0.983 |
| 1:182527633:C:G | F662L | 0.983 |
| 1:182532710:T:G | Y805D | 0.983 |
| 1:182548819:G:C | W976C | 0.983 |
| 1:182548819:G:T | W976C | 0.983 |
| 1:182540394:A:G | D881G | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000031543 (1:182457333 C>T), RS1000066014 (1:182516014 A>G), RS1000080951 (1:182470135 C>G), RS1000104361 (1:182495773 C>A), RS1000145100 (1:182516270 G>A), RS1000150027 (1:182463957 T>A,C), RS1000153332 (1:182493677 ATGTGAATGCCCC>A), RS1000165282 (1:182482493 A>C), RS1000262155 (1:182482130 A>G), RS1000310684 (1:182540880 T>C,G), RS1000346552 (1:182451687 T>C), RS1000381442 (1:182534599 C>T), RS1000408333 (1:182484223 T>C), RS1000429942 (1:182508682 T>G), RS1000456035 (1:182491214 AATT>A,AATTATT)
Disease associations
OMIM: gene MIM:611012 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005183_7 | Common carotid intima-media thickness | 3.000000e-06 |
| GCST007565_112 | Morning person | 7.000000e-30 |
| GCST011359_19 | Venous thromboembolism | 1.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008328 | chronotype measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| fluorene-9-bisphenol | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Permethrin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): venous thromboembolism